Prevalence and Characteristics of Taste Disorders in Cases of COVID‐19: A Meta‐analysis of 29,349 Patients

Abstract

Objective The purpose of this meta-analysis is to assess the pooled prevalence of taste disorders and their subtypes in patients with COVID-19. Data Sources PubMed, Scopus, Web of Science, Embase, and Google Scholar databases were searched to identify studies published between December 1, 2019, and June 23, 2020, without language restrictions. There was no restriction on the study design; therefore, observational studies, clinical trials, and case series were included. In addition, preprints were considered if data of interest were reported. Review Methods Two authors independently screened articles for eligibility. A random effects model was used to estimate the pooled prevalence with 95% CIs. Quality assessment was done with critical appraisal tools of the Joanna Briggs Institute. The robustness of the pooled estimates was checked by subgroup and sensitivity analyses. Results Fifty-nine studies were included (N = 29,349 patients, 64.4% female). The pooled prevalence of taste disorders in patients with COVID-19 was 48.1% (95% CI, 41.3%-54.8%). The prevalence of taste disorders in studies with objective assessments was higher as compared with subjective assessments (59.2% vs 47.3%). The disorders were observed in 55.2% of European patients; 61.0%, North American; 27.1%, Asian; 29.5%, South American; and 25.0%, Australian. Ageusia, hypogeusia, and dysgeusia were detected in 28.0%, 33.5%, and 41.3% of patients with COVID-19. We identified 91.5% of the included studies as high quality. Conclusions The prevalence of taste disorders in patients with COVID-19 was 48.1%. Objective assessments have higher prevalence than subjective assessments. Dysgeusia is the most common subtype, followed by ageusia and hypogeusia.

Global Financial Crisis, Smart Lockdown Strategies, and the COVID-19 Spillover Impacts: A Global Perspective Implications From Southeast Asia

“…This virus' (COVID-19) symptoms vary; nevertheless they most commonly include fever (17), headache, cough (18) fatigue, breathing difficulties, a loss of taste, and a loss of sense of smell (19)(20)(21)(22). The virus attack can appear from day one to fifteen or even longer after exposure to the infected person or environment.…”

Diagnostic Accuracy of Rapid Antigen Test Kits for Detecting SARS-CoV-2: A Systematic Review and Meta-Analysis of 17,171 Suspected COVID-19 Patients

“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease 2019 (COVID- 19), characterised mainly by fever, cough, sore throat, fatigue, joint and muscle pain and loss of smell and taste [1][2][3][4][5]. It was first identified in Hubei province in Wuhan, China, in December 2019 and until now, it continues to be a significant health issue worldwide.…”

Impact of COVID-19 on Czech Dentistry: A Nationwide Cross-Sectional Preliminary Study among Dentists in the Czech Republic

“…Coronavirus disease 2019 (COVID-19) is a contagious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Symptoms of COVID-19 are variable, ranging from mild to deadly, including fever, cough, headache, fatigue, loss of smell and taste, breathing difficulties, respiratory failure, or acute inflammatory response (cytokine storm) [1][2][3][4][5][6]. The human-to-human transmission is caused by respiratory droplets, either by being inhaled or deposited on mucosal surfaces and via direct contact of mucous membranes, such as oral, nasal, or eye [7].…”